Read the docs
TI-2025-07005 Aliases CVE-2025-7674GHSA-j88v-x2vj-xcj6

navify Monitoring API input validation

Priority LOW 37CWE-20Published · Updated

Key facts

Attack vector
Network
Privileges required
Low
User interaction
None
Attack complexity
Low
Attack requirements
None
Impact type
—
Confidentiality · integrity · availability
None · None · High
Fix status
Fixed

Attack profile from CVSS 4.0 · CNA. Fix status from CNA.

Summary

Improper Input Validation vulnerability in Roche Diagnostics navify Monitoring allows an attacker to manipulate input data, which may lead to a denial of service (DoS) due to negatively impacting the server's performance. This vulnerability has no impact on data confidentiality or integrity. This issue affects navify Monitoring before 1.08.00.

Why it matters now

Exploitation None reported CISA SSVC · not in CISA KEV
EPSS 0.00325 25th percentileScored 2026-11-07
Fix Fixed navify Monitoring (Roche Diagnostics): 1.08.00

SSVC decision points

CISA ADP · SSVC 2.0.3

Exploitation
None
Automatable
Yes
Technical impact
Partial

The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.

Affected products

VendorProductAffected versionsFixed inStatusSource
Roche Diagnosticsnavify Monitoringbefore 1.08.001.08.00Patch availableCNA
  • navify Monitoring VendorRoche Diagnostics Affected before 1.08.00 Fixed in 1.08.00 Patch available CNA

Remediation

  • Fix · CNA navify Monitoring (Roche Diagnostics) Fixed in 1.08.00

Timeline

  1. 2026-10-02 Threatist record created from CVE-2025-7674
  2. 2026-10-03 Alias added: GHSA-j88v-x2vj-xcj6

References

Advisory 1

  • TI-2026-08618 Vulnerability in navify® Digital Pathology CVSS 4.0HIGH 8.8
  • TI-2024-12075 Inadequate Encryption Strength Vulnerability in Roche Algo Edge CVSS 4.0MEDIUM 6.1

Sources

This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences